First Manhattan CO. LLC. Has $90.07 Million Stock Position in Cencora, Inc. $COR

Posted by Brenda Bartman on Jun 18th, 2026

First Manhattan CO. LLC. cut its holdings in Cencora, Inc. (NYSE:COR – Free Report) by 2.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 266,675 shares of the company’s stock after selling 7,737 shares during the quarter. First Manhattan CO. LLC.’s holdings in Cencora were worth $90,069,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of COR. United Bank raised its stake in Cencora by 4.5% during the second quarter. United Bank now owns 7,032 shares of the company’s stock worth $2,109,000 after acquiring an additional 305 shares in the last quarter. Nebula Research & Development LLC acquired a new position in Cencora during the second quarter worth about $595,000. Treasurer of the State of North Carolina raised its stake in Cencora by 7.9% during the second quarter. Treasurer of the State of North Carolina now owns 85,534 shares of the company’s stock worth $25,647,000 after acquiring an additional 6,244 shares in the last quarter. Diversify Advisory Services LLC raised its stake in Cencora by 94.1% during the second quarter. Diversify Advisory Services LLC now owns 2,585 shares of the company’s stock worth $747,000 after acquiring an additional 1,253 shares in the last quarter. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main raised its stake in Cencora by 26.0% during the second quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 73,452 shares of the company’s stock worth $22,025,000 after acquiring an additional 15,154 shares in the last quarter. Institutional investors and hedge funds own 97.52% of the company’s stock.

Analysts Set New Price Targets

COR has been the subject of several research analyst reports. Leerink Partners reissued an “outperform” rating on shares of Cencora in a research note on Tuesday, March 17th. Morgan Stanley set a $342.00 target price on Cencora in a research note on Friday, May 8th. Robert W. Baird lowered their target price on Cencora from $420.00 to $339.00 and set an “outperform” rating for the company in a research note on Thursday, May 7th. Citigroup lowered their target price on Cencora from $405.00 to $355.00 and set a “buy” rating for the company in a report on Thursday, May 7th. Finally, Weiss Ratings cut Cencora from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, May 22nd. Twelve equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $374.00.

Check Out Our Latest Report on Cencora

Cencora Price Performance

Shares of COR opened at $277.10 on Thursday. Cencora, Inc. has a 12-month low of $244.82 and a 12-month high of $377.54. The business has a 50-day simple moving average of $286.62 and a two-hundred day simple moving average of $325.41. The company has a quick ratio of 0.59, a current ratio of 0.95 and a debt-to-equity ratio of 3.40. The stock has a market cap of $53.91 billion, a PE ratio of 21.25, a PEG ratio of 1.52 and a beta of 0.59.

Cencora (NYSE:COR – Get Free Report) last issued its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a return on equity of 135.20% and a net margin of 0.78%.The firm had revenue of $78.36 billion during the quarter, compared to analyst estimates of $81.09 billion. During the same period in the previous year, the company earned $4.42 EPS. Cencora’s revenue for the quarter was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Analysts anticipate that Cencora, Inc. will post 17.79 earnings per share for the current fiscal year.

Cencora announced that its board has approved a share repurchase plan on Thursday, May 21st that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the company to buy up to 3.9% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s management believes its stock is undervalued.

Cencora Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were issued a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend was Friday, May 15th. Cencora’s dividend payout ratio is presently 18.40%.

About Cencora

(Free Report)

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.